Cornerstone Therapeutics Inc. Appoints General Counsel
11/13/2009 10:10:36 AM
More...
|
Cornerstone Therapeutics Inc. Reports Third Quarter 2009 Financial Results
11/4/2009 8:53:29 AM
More...
|
Cornerstone Therapeutics Inc. to Host Third Quarter 2009 Conference Call
10/21/2009 9:22:14 AM
More...
|
Cornerstone Therapeutics Inc. Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R) for $5 Million
9/3/2009 6:44:48 AM
More...
|
Cornerstone Therapeutics Inc. Reports Second Quarter and First Half 2009 Financial Results
8/11/2009 10:28:36 AM
More...
|
Cornerstone Therapeutics Inc. Announces Closing of Chiesi Farmaceutici SpA Transaction
7/30/2009 8:45:22 AM
More...
|
Cornerstone Therapeutics Inc.' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal
7/20/2009 9:39:19 AM
More...
|
Cornerstone Therapeutics Inc. Submits Regulatory Filing for Extended-Release Antitussive Product
7/16/2009 8:16:03 AM
More...
|
Oscient Pharmaceuticals Corporation (OSCI) Files for Bankruptcy; Sell its Antibiotic Drug Factive to Cornerstone Therapeutics Inc. Unit for $5 Million
7/14/2009 7:20:20 AM
More...
|
Cornerstone Therapeutics, Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Charter Amendments
7/9/2009 7:51:47 AM
More...
|
|